Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KC-4347

HCT116-BRCA2-KO 1A3 Cell Line

Home » HCT116-BRCA2-KO 1A3 Cell Line

Background of HCT116-BRCA2-KO 1A3 Cell Line

The BRCA2 is located in region 12 of the long arm of chromosome 13 and consists of 27 coding exons, the largest being exon 11 (4.9 kb). BRCA2 encodes a protein of 3418 amino acids (10.2 kb). The N-terminus of BRCA2 binds to PALB2. In addition, BRCA2 contains 8 BRC repeats located between amino acid residues 1009 to 2083 and binds to RAD51. The BRCA2 gene DNA binding domain contains 5 components: a 190 amino acid alpha helix domain (H), 3 oligonucleotide binding folds (single-stranded DNA binding module), and a tower-like domain (T) that extends from 3 oligonucleotide binding 2 and binds to dsDNA to bind single-stranded DNA. The C-terminus of BRCA2 contains an NLS and a phosphorylation site S3291 for cyclin-dependent kinase, which also binds to RAD51.
The BRCA2 gene mediates the recruitment of RAD51 filaments to the DNA double-strand break site and interacts in the repair process to form the RAD51-BRCA2-DSS1 complex, which uses sister chromatids as a template to repair damage through “error-free” homologous recombination. The BRCA2 gene also appears to participate in cytoplasmic division; when its function is disrupted, cytoplasmic division is impaired, and the incidence of binucleated cells is increased. Studies have also shown that BRCA2 gene-deficient cells exhibit alterations in chromosome number (aneuploidy) as well as structurally abnormal chromosomes, resulting in BRCA2 gene-deficient tumors that are frequently aneuploid. In addition to its DNA repair function, BRCA2 inhibits tumor development by suppressing cancer cell growth.

Specifications

Catalog Number:
KC-4347-DW
Cell Line Name:
HCT116-BRCA2-KO
Clone Number
Host Cell Line:
HCT116
Description:
Stable HCT116 cell line with human BRCA2 gene knockout, No.1A3
Quantity:
Two vials of frozen cells (2-5×106/vial)
Stability:
Stable in culture over a minimum of 10 passages
Application:
Drug screening and biological assays
Freezing Medium:
70% McCoy's 5a + 20% FBS + 10% DMSO
Propagation Medium:
McCoy's 5a + 10% FBS
Selection Marker:
NA
Morphology:
Fibroblastoid cells growing as a monolayer
Subculture:
Split the saturated culture at a ratio of 1:4~1:5 every 2~3 days; seed out at about 1-3 x 105 cells/ml
Incubation:
37 °C with 5% CO2
Storage:
Liquid nitrogen immediately upon receiving
Doubling Time:
Approximately 30 hours
Mycoplasma Status:
Negative
In Vivo Validation:
Yes

Cell Line Generation

HCT116-BRCA2-KO 1A3 cell line was generated using the CRISPR method.

Characterization

Figure 1: Characterization of HCT116-BRCA2-KO 1A3 Cell Line stable clone using PCR sequencing.

Figure 2: Characterization of HCT116-BRCA2-KO 1A3 Cell Line stable clone using RT-PCR sequencing.

Figure 3: Characterization of Dose-response curves and IC50 values for HCT116 and HCT116-BRCA2-KO 1A3 cells treated with Olaparib,ART558,Talazoparib,Pamiparib,Fluzoparib and Niraparib over 5 days.

Cell Resuscitation

  1. Prewarm culture medium (McCoy's 5a + 10% FBS)in a 37°C water bath.
  2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
  3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
  4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
  5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
  6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
  7. Incubate the flask at 37°C, 5% CO2 incubator.
  8. Split the saturated culture at a ratio of 1:4 ~ 1:5 every 2~3 days; seed out at about 1-3 x 105 cells/mL.

Cell Freezing

  1. Prepare the freezing medium (70% McCoy's 5a + 20% FBS + 10% DMSO) fresh immediately before use.
  2. Keep the freezing medium on ice and label cryovials.
  3. Transfer cells to a sterile, conical centrifuge tube, and count the cells.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
  5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium.
  6. Aliquot 1 mL of the cell suspension into each cryovial.
  7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
  8. Transfer vials to liquid nitrogen for long-term storage.

References

  1. Xie C, Luo J, He Y, Jiang L, Zhong L, Shi Y. BRCA2 gene mutation in cancer. Medicine (Baltimore). 2022 Nov 11;101(45):e31705. doi: 10.1097/MD.0000000000031705. PMID: 36397405; PMCID: PMC9666215.